Literature DB >> 20451074

[Lung metastases of epithelioid sarcoma revealed by bilateral spontaneous pneumothorax: a pathological diagnosis].

Raphaëlle Barnoud1, Sophie Collardeau-Frachon, Eric de la Roche, Alexandre Vasiljevic, Vivien Thomson, Dominique Ranchère, Gilles Devouassoux, Mojgan Devouassoux-Shisheboran.   

Abstract

Spontaneous pneumothorax may be one of the presenting manifestation of metastatic epithelioid sarcoma even if imaging does not show evident metastatic nodules. We report the case of a 24-year-old man presenting a bilateral spontaneous pneumothorax in association with an epithelioid sarcoma developed in the right foot. CT-scan revealed bilateral microcystic lesions with no evidence of metastatic disease. A left thoracoscopy and a pleurodesis were performed. Persistent air leakage led to a thoracotomy during which lung biopsies were carried out. Histopathological examination of the pulmonary biopsies revealed rare millimetric nodules, composed of very atypical epithelioid cells, growing along alveolar walls reminiscent of a bronchiolo-alveolar carcinoma. However, these cells and primary neoplastic cells of the foot tumour were morphologically and immunohistochemically similar and the atypical pulmonary cells were TTF1 negative. All these constatations allowed a diagnosis of pulmonary metastases of the epithelioid sarcoma. This very unusual case underlines that sarcomatous metastases may be a clinical and pathological pitfall. Copyright 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20451074     DOI: 10.1016/j.annpat.2010.01.004

Source DB:  PubMed          Journal:  Ann Pathol        ISSN: 0242-6498            Impact factor:   0.407


  2 in total

Review 1.  Epithelioid sarcoma with spontaneous pneumothorax and massive pleural effusion.

Authors:  So-Yeon Jeon; Ho-Young Yhim; Na-Ri Lee
Journal:  Korean J Intern Med       Date:  2015-12-28       Impact factor: 2.884

2.  Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study.

Authors:  Bruce Sabath; Hasan A Muhammad; Amulya Balagani; David E Ost; Erik Vakil; Tahreem Ahmed; Macarena R Vial; Horiana B Grosu
Journal:  BMC Cancer       Date:  2018-10-01       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.